| Literature DB >> 18440229 |
Philip Jones1, Matthew J Bottomley, Andrea Carfí, Ottavia Cecchetti, Federica Ferrigno, Paola Lo Surdo, Jesus M Ontoria, Michael Rowley, Rita Scarpelli, Carsten Schultz-Fademrecht, Christian Steinkühler.
Abstract
The identification of class II HDAC inhibitors has been hampered by lack of efficient enzyme assays, in the preceding paper two assays have been developed to improve the efficiency of these enzymes: mutating an active site histidine to tyrosine, or by the use of a trifluoroacetamide lysine substrate, allowing screening to identify class II HDAC inhibitors. Herein, 2-trifluoroacetylthiophenes have been demonstrated to inhibit class II HDACs, resulting in the development of a series of 5-(trifluoroacetyl)thiophene-2-carboxamides as novel, potent and selective class II HDAC inhibitors. X-ray crystal structures of the HDAC 4 catalytic domain with a bound inhibitor demonstrate these compounds are active site inhibitors and bind in their hydrated form.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18440229 DOI: 10.1016/j.bmcl.2008.02.026
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823